{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:00:25Z","timestamp":1788908425932,"version":"build-2803163510"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,4,6]],"date-time":"2013-04-06T00:00:00Z","timestamp":1365206400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ADHD Atten Def Hyp Disord"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s12402-013-0106-x","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T17:49:10Z","timestamp":1365184150000},"page":"249-265","source":"Crossref","is-referenced-by-count":37,"title":["Long-acting stimulants for treatment of attention-deficit\/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges"],"prefix":"10.1007","volume":"5","author":[{"given":"Frank A.","family":"L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques R.","family":"Leroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,6]]},"reference":[{"issue":"1","key":"106_CR1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1017\/S0033291706008713","volume":"37","author":"SL Able","year":"2007","unstructured":"Able SL, Johnston JA, Adler LA, Swindle RW (2007) Functional and psychosocial impairment in adults with undiagnosed ADHD. Psychol Med 37(1):97\u2013107. doi: 10.1017\/S0033291706008713","journal-title":"Psychol Med"},{"issue":"1","key":"106_CR2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3810\/pgm.2010.01.2112","volume":"122","author":"LD Adler","year":"2010","unstructured":"Adler LD, Nierenberg AA (2010) Review of medication adherence in children and adults with ADHD. Postgrad Med 122(1):184\u2013191. doi: 10.3810\/pgm.2010.01.2112","journal-title":"Postgrad Med"},{"issue":"9","key":"106_CR3","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.4088\/JCP.v69n0903","volume":"69","author":"LA Adler","year":"2008","unstructured":"Adler LA, Goodman DW, Kollins SH, Weisler RH, Krishnan S, Zhang Y, Biederman J (2008) Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder. J Clin Psychiatry 69(9):1364\u20131373","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"106_CR4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/JCP.0b013e3181a390ce","volume":"29","author":"LA Adler","year":"2009","unstructured":"Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T (2009) Efficacy and safety of OROS methylphenidate in adults with attention-deficit\/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. J Clin Psychopharmacol 29(3):239\u2013247. doi: 10.1097\/JCP.0b013e3181a390ce","journal-title":"J Clin Psychopharmacol"},{"key":"106_CR5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1542\/peds.2011-2107B","volume":"128","author":"American Academy of Pediatrics","year":"2011","unstructured":"American Academy of Pediatrics (2011) ADHD: clinical Practice Guideline for the diagnosis, evaluation, and treatment of attention-deficit\/hyperactivity disorder in children and adolescents. Pediatrics 128:1007\u20131022","journal-title":"Pediatrics"},{"key":"106_CR6","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890423349","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). American Psychiatric Association, Washington DC"},{"key":"106_CR7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1741-7015-9-72","volume":"9","author":"KM Antshel","year":"2011","unstructured":"Antshel KM, Hargrave TM, Simonescu M, Kaul P, Hendricks K, Faraone SV (2011) Advances in understanding and treating ADHD. BMC Med 9:72. doi: 10.1186\/1741-7015-9-72","journal-title":"BMC Med"},{"key":"106_CR8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1177\/1087054711425772","volume":"16","author":"RB Armstrong","year":"2012","unstructured":"Armstrong RB, Damaraju CV, Ascher S, Schwarzman L, O\u2019Neill J, Starr HL (2012) Time course of treatment effect of OROS(R) methylphenidate in children with ADHD. J Atten Disord 16:697\u2013705. doi: 10.1177\/1087054711425772","journal-title":"J Atten Disord"},{"issue":"4","key":"106_CR9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/108705470000300403","volume":"3","author":"LE Arnold","year":"2000","unstructured":"Arnold LE (2000) Methylphenidate vs. amphetamine: comparative review. J Atten Disord 3(4):200\u2013211. doi: 10.1177\/108705470000300403","journal-title":"J Atten Disord"},{"issue":"8","key":"106_CR10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00787-006-0549-0","volume":"15","author":"T Banaschewski","year":"2006","unstructured":"Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Dopfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJ, Taylor E (2006) Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry 15(8):476\u2013495. doi: 10.1007\/s00787-006-0549-0","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"2","key":"106_CR11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.chi.0000189134.97436.e2","volume":"45","author":"RA Barkley","year":"2006","unstructured":"Barkley RA, Fischer M, Smallish L, Fletcher K (2006) Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 45(2):192\u2013202. doi: 10.1097\/01.chi.0000189134.97436.e2","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"9481","key":"106_CR12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0140-6736(05)66915-2","volume":"366","author":"J Biederman","year":"2005","unstructured":"Biederman J, Faraone SV (2005) Attention-deficit hyperactivity disorder. Lancet 366(9481):237\u2013248. doi: 10.1016\/s0140-6736(05)66915-2","journal-title":"Lancet"},{"issue":"2 Pt 1","key":"106_CR13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1542\/peds.110.2.258","volume":"110","author":"J Biederman","year":"2002","unstructured":"Biederman J, Lopez FA, Boellner SW, Chandler MC (2002) A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit\/hyperactivity disorder. Pediatrics 110(2 Pt 1):258\u2013266","journal-title":"Pediatrics"},{"issue":"4","key":"106_CR14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4088\/JCP.v67n0403","volume":"67","author":"J Biederman","year":"2006","unstructured":"Biederman J, Faraone SV, Spencer TJ, Mick E, Monuteaux MC, Aleardi M (2006a) Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community. J Clin Psychiatry 67(4):524\u2013540","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"106_CR15","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.biopsych.2005.09.011","volume":"59","author":"J Biederman","year":"2006","unstructured":"Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, Dunkel S, Dougherty M, Aleardi M, Spencer T (2006b) A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit\/hyperactivity disorder. Biol Psychiatry 59(9):829\u2013835. doi: 10.1016\/j.biopsych.2005.09.011","journal-title":"Biol Psychiatry"},{"issue":"9","key":"106_CR16","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.biopsych.2007.04.015","volume":"62","author":"J Biederman","year":"2007","unstructured":"Biederman J, Boellner SW, Childress A, Lopez FA, Krishnan S, Zhang Y (2007a) Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study. Biol Psychiatry 62(9):970\u2013976. doi: 10.1016\/j.biopsych.2007.04.015","journal-title":"Biol Psychiatry"},{"issue":"3","key":"106_CR17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0149-2918(07)80083-X","volume":"29","author":"J Biederman","year":"2007","unstructured":"Biederman J, Krishnan S, Zhang Y, McGough JJ, Findling RL (2007b) Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit\/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. Clin Ther 29(3):450\u2013463","journal-title":"Clin Ther"},{"issue":"2","key":"106_CR18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.clinthera.2010.02.011","volume":"32","author":"SW Boellner","year":"2010","unstructured":"Boellner SW, Stark JG, Krishnan S, Zhang Y (2010) Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit\/hyperactivity disorder: a single-dose, randomized, open-label, crossover study. Clin Ther 32(2):252\u2013264. doi: 10.1016\/j.clinthera.2010.02.011","journal-title":"Clin Ther"},{"key":"106_CR19","unstructured":"Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA) CADDRA response to new ADHD Generic Medication: Novo-Methylphenidate ER-C. June 3, 2010. http:\/\/www.caddra.ca\/cms4\/index.php?option=com_content&view=article&id=181&Itemid=356&lang=en . Accessed March 1, 2012"},{"key":"106_CR20","unstructured":"Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA) (2011) Canadian ADHD Practice Guidelines (CAP-Guidelines). http:\/\/wwwcaddraca\/cms4\/pdfs\/caddraGuidelines2011pdf . Accessed January 2013"},{"key":"106_CR21","author":"M Casas","year":"2011","unstructured":"Casas M, Rosler M, Sandra Kooij JJ, Ginsberg Y, Ramos-Quiroga JA, Heger S, Berwaerts J, Dejonckheere J, van der Vorst E, Schauble B (2011) Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit\/hyperactivity disorder: a 13-week, randomized, double-blind, placebo-controlled, fixed-dose study. World J Biol Psychiatry. doi: 10.3109\/15622975.2011.600333","journal-title":"World J Biol Psychiatry"},{"issue":"4","key":"106_CR22","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1185\/03007991003673617","volume":"26","author":"L Christensen","year":"2010","unstructured":"Christensen L, Sasane R, Hodgkins P, Harley C, Tetali S (2010) Pharmacological treatment patterns among patients with attention-deficit\/hyperactivity disorder: retrospective claims-based analysis of a managed care population. Curr Med Res Opin 26(4):977\u2013989. doi: 10.1185\/03007991003673617","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"106_CR23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1753-2000-2-31","volume":"2","author":"D Coghill","year":"2008","unstructured":"Coghill D, Soutullo C, d\u2019Aubuisson C, Preuss U, Lindback T, Silverberg M, Buitelaar J (2008) Impact of attention-deficit\/hyperactivity disorder on the patient and family: results from a European survey. Child Adolesc Psychiatry Ment Health 2(1):31. doi: 10.1186\/1753-2000-2-31","journal-title":"Child Adolesc Psychiatry Ment Health"},{"issue":"20","key":"106_CR24","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1056\/NEJMoa1110212","volume":"365","author":"WO Cooper","year":"2011","unstructured":"Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O\u2019Duffy A, Connell FA, Ray WA (2011) ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 365(20):1896\u20131904. doi: 10.1056\/NEJMoa1110212","journal-title":"N Engl J Med"},{"issue":"5 Suppl","key":"106_CR25","first-page":"S141","volume":"15","author":"JA Dopheide","year":"2009","unstructured":"Dopheide JA (2009) The role of pharmacotherapy and managed care pharmacy interventions in the treatment of ADHD. Am J Manag Care 15(5 Suppl):S141\u2013S150","journal-title":"Am J Manag Care"},{"issue":"9","key":"106_CR26","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1177\/0091270009357346","volume":"50","author":"J Ermer","year":"2010","unstructured":"Ermer J, Homolka R, Martin P, Buckwalter M, Purkayastha J, Roesch B (2010a) Lisdexamfetamine dimesylate: linear dose-proportionality, low intersubject and intrasubject variability, and safety in an open-label single-dose pharmacokinetic study in healthy adult volunteers. J Clin Pharmacol 50(9):1001\u20131010. doi: 10.1177\/0091270009357346","journal-title":"J Clin Pharmacol"},{"issue":"12","key":"106_CR27","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2165\/11539410-000000000-00000","volume":"24","author":"JC Ermer","year":"2010","unstructured":"Ermer JC, Adeyi BA, Pucci ML (2010b) Pharmacokinetic variability of long-acting stimulants in the treatment of children and adults with attention-deficit hyperactivity disorder. CNS Drugs 24(12):1009\u20131025. doi: 10.2165\/11539410-000000000-00000","journal-title":"CNS Drugs"},{"issue":"6","key":"106_CR28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2165\/11588190-000000000-00000","volume":"31","author":"JC Ermer","year":"2011","unstructured":"Ermer JC, Dennis K, Haffey MB, Doll WJ, Sandefer EP, Buckwalter M, Page RC, Diehl B, Martin PT (2011) Intranasal versus oral administration of lisdexamfetamine dimesylate: a randomized, open-label, two-period, crossover, single-dose, single-centre pharmacokinetic study in healthy adult men. Clin Drug Investig 31(6):357\u2013370. doi: 10.2165\/11588190-000000000-00000","journal-title":"Clin Drug Investig"},{"issue":"12","key":"106_CR29","first-page":"678","volume":"34","author":"SV Faraone","year":"2009","unstructured":"Faraone SV (2009) Using Meta-analysis to Compare the Efficacy of Medications for Attention-Deficit\/Hyperactivity Disorder in Youths. P T 34(12):678\u2013694","journal-title":"P T"},{"issue":"2","key":"106_CR30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/1087054710379738","volume":"16","author":"SV Faraone","year":"2012","unstructured":"Faraone SV (2012) Understanding the effect size of lisdexamfetamine dimesylate for treating ADHD in children and adults. J Atten Disord 16(2):128\u2013137. doi: 10.1177\/1087054710379738","journal-title":"J Atten Disord"},{"issue":"6","key":"106_CR31","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4088\/JCP.08m04902pur","volume":"71","author":"SV Faraone","year":"2010","unstructured":"Faraone SV, Glatt SJ (2010) A comparison of the efficacy of medications for adult attention-deficit\/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry 71(6):754\u2013763. doi: 10.4088\/JCP.08m04902pur","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"106_CR32","first-page":"4","volume":"8","author":"SV Faraone","year":"2006","unstructured":"Faraone SV, Biederman J, Spencer TJ, Aleardi M (2006) Comparing the efficacy of medications for ADHD using meta-analysis. MedGenMed 8(4):4","journal-title":"MedGenMed"},{"issue":"9","key":"106_CR33","first-page":"994","volume":"47","author":"SV Faraone","year":"2008","unstructured":"Faraone SV, Biederman J, Morley CP, Spencer TJ (2008) Effect of stimulants on height and weight: a review of the literature. J Am Acad Child Adolesc Psychiatry 47(9):994\u20131009. doi: 10.1097\/CHI.ObO13e31817eOea7","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"106_CR34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00004583-200105000-00011","volume":"40","author":"RL Findling","year":"2001","unstructured":"Findling RL, Short EJ, Manos MJ (2001) Short-term cardiovascular effects of methylphenidate and adderall. J Am Acad Child Adolesc Psychiatry 40(5):525\u2013529. doi: 10.1097\/00004583-200105000-00011","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"106_CR35","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jpeds.2005.03.014","volume":"147","author":"RL Findling","year":"2005","unstructured":"Findling RL, Biederman J, Wilens TE, Spencer TJ, McGough JJ, Lopez FA, Tulloch SJ (2005) Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children. J Pediatr 147(3):348\u2013354. doi: 10.1016\/j.jpeds.2005.03.014","journal-title":"J Pediatr"},{"issue":"4","key":"106_CR36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaac.2011.01.007","volume":"50","author":"RL Findling","year":"2011","unstructured":"Findling RL, Childress AC, Cutler AJ, Gasior M, Hamdani M, Ferreira-Cornwell MC, Squires L (2011) Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 50(4):395\u2013405. doi: 10.1016\/j.jaac.2011.01.007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"106_CR37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5414\/CPP40175","volume":"40","author":"MA Gonzalez","year":"2002","unstructured":"Gonzalez MA, Pentikis HS, Anderl N, Benedict MF, DeCory HH, Dirksen SJ, Hatch SJ (2002) Methylphenidate bioavailability from two extended-release formulations. Int J Clin Pharmacol Ther 40(4):175\u2013184","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"1","key":"106_CR38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00787-010-0140-6","volume":"20","author":"J Graham","year":"2011","unstructured":"Graham J, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Dopfner M, Hamilton R, Hollis C, Holtmann M, Hulpke-Wette M, Lecendreux M, Rosenthal E, Rothenberger A, Santosh P, Sergeant J, Simonoff E, Sonuga-Barke E, Wong IC, Zuddas A, Steinhausen HC, Taylor E (2011) European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry 20(1):17\u201337. doi: 10.1007\/s00787-010-0140-6","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"24","key":"106_CR39","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.2011.1830","volume":"306","author":"LA Habel","year":"2011","unstructured":"Habel LA, Cooper WO, Sox CM, Chan KA, Fireman BH, Arbogast PG, Cheetham TC, Quinn VP, Dublin S, Boudreau DM, Andrade SE, Pawloski PA, Raebel MA, Smith DH, Achacoso N, Uratsu C, Go AS, Sidney S, Nguyen-Huynh MN, Ray WA, Selby JV (2011) ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA 306(24):2673\u20132683. doi: 10.1001\/jama.2011.1830","journal-title":"JAMA"},{"issue":"5","key":"106_CR40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3810\/pgm.2009.09.2048","volume":"121","author":"MB Haffey","year":"2009","unstructured":"Haffey MB, Buckwalter M, Zhang P, Homolka R, Martin P, Lasseter KC, Ermer JC (2009) Effects of omeprazole on the pharmacokinetic profiles of lisdexamfetamine dimesylate and extended-release mixed amphetamine salts in adults. Postgrad Med 121(5):11\u201319. doi: 10.3810\/pgm.2009.09.2048","journal-title":"Postgrad Med"},{"issue":"2","key":"106_CR41","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4088\/JCP.v68n0213","volume":"68","author":"U Jain","year":"2007","unstructured":"Jain U, Hechtman L, Weiss M, Ahmed TS, Reiz JL, Donnelly GA, Harsanyi Z, Darke AC (2007) Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit\/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study. J Clin Psychiatry 68(2):268\u2013277","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"106_CR42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1753-2000-5-35","volume":"5","author":"R Jain","year":"2011","unstructured":"Jain R, Babcock T, Burtea T, Dirks B, Adeyi B, Scheckner B, Lasser R (2011) Efficacy of lisdexamfetamine dimesylate in children with attention-deficit\/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis. Child Adolesc Psychiatry Ment Health 5(1):35. doi: 10.1186\/1753-2000-5-35","journal-title":"Child Adolesc Psychiatry Ment Health"},{"issue":"11","key":"106_CR43","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/00004583-200111000-00006","volume":"40","author":"RS James","year":"2001","unstructured":"James RS, Sharp WS, Bastain TM, Lee PP, Walter JM, Czarnolewski M, Castellanos FX (2001) Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD. J Am Acad Child Adolesc Psychiatry 40(11):1268\u20131276. doi: 10.1097\/00004583-200111000-00006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"106_CR44","unstructured":"Janssen Inc. Concerta\u00ae Product Monograph. Revised December 5, 2011. http:\/\/www.janssen.ca\/product\/98 . Accessed 2 July 2012. Janssen Inc., Toronto, Ontario"},{"issue":"4","key":"106_CR45","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/0269881109103113","volume":"23","author":"DR Jasinski","year":"2009","unstructured":"Jasinski DR, Krishnan S (2009a) Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse. J Psychopharmacol 23(4):419\u2013427. doi: 10.1177\/0269881109103113","journal-title":"J Psychopharmacol"},{"issue":"4","key":"106_CR46","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0269881108093841","volume":"23","author":"DR Jasinski","year":"2009","unstructured":"Jasinski DR, Krishnan S (2009b) Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers. J Psychopharmacol 23(4):410\u2013418. doi: 10.1177\/0269881108093841","journal-title":"J Psychopharmacol"},{"issue":"4","key":"106_CR47","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1176\/appi.ajp.163.4.716","volume":"163","author":"RC Kessler","year":"2006","unstructured":"Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE, Zaslavsky AM (2006) The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163(4):716\u2013723. doi: 10.1176\/appi.ajp.163.4.716","journal-title":"Am J Psychiatry"},{"issue":"5","key":"106_CR48","doi-asserted-by":"crossref","first-page":"e541","DOI":"10.1542\/peds.2004-0844","volume":"114","author":"AF Klassen","year":"2004","unstructured":"Klassen AF, Miller A, Fine S (2004) Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit\/hyperactivity disorder. Pediatrics 114(5):e541\u2013e547. doi: 10.1542\/peds.2004-0844","journal-title":"Pediatrics"},{"issue":"2","key":"106_CR49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/1087054707311654","volume":"12","author":"SH Kollins","year":"2008","unstructured":"Kollins SH (2008) ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines. J Atten Disord 12(2):115\u2013125. doi: 10.1177\/1087054707311654","journal-title":"J Atten Disord"},{"issue":"3","key":"106_CR50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0091270007310381","volume":"48","author":"S Krishnan","year":"2008","unstructured":"Krishnan S, Zhang Y (2008) Relative bioavailability of lisdexamfetamine 70-mg capsules in fasted and fed healthy adult volunteers and in solution: a single-dose, crossover pharmacokinetic study. J Clin Pharmacol 48(3):293\u2013302. doi: 10.1177\/0091270007310381","journal-title":"J Clin Pharmacol"},{"issue":"8","key":"106_CR51","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2165\/00148581-200305080-00005","volume":"5","author":"F Lopez","year":"2003","unstructured":"Lopez F, Silva R, Pestreich L, Muniz R (2003) Comparative efficacy of two once daily methylphenidate formulations (Ritalin LA and Concerta) and placebo in children with attention deficit hyperactivity disorder across the school day. Paediatr Drugs 5(8):545\u2013555","journal-title":"Paediatr Drugs"},{"issue":"4","key":"106_CR52","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.pra.0000400261.45290.bd","volume":"17","author":"AR Mao","year":"2011","unstructured":"Mao AR, Babcock T, Brams M (2011) ADHD in adults: current treatment trends with consideration of abuse potential of medications. J Psychiatr Pract 17(4):241\u2013250. doi: 10.1097\/01.pra.0000400261.45290.bd","journal-title":"J Psychiatr Pract"},{"issue":"6","key":"106_CR53","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/archpedi.159.6.572","volume":"159","author":"SC Marcus","year":"2005","unstructured":"Marcus SC, Wan GJ, Kemner JE, Olfson M (2005) Continuity of methylphenidate treatment for attention-deficit\/hyperactivity disorder. Arch Pediatr Adolesc Med 159(6):572\u2013578. doi: 10.1001\/archpedi.159.6.572","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"106_CR54","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1517\/14656566.2011.546058","volume":"12","author":"K McBurnett","year":"2011","unstructured":"McBurnett K, Starr HL (2011) OROS methylphenidate hydrochloride for adult patients with attention deficit\/hyperactivity disorder. Expert Opin Pharmacother 12(2):315\u2013324. doi: 10.1517\/14656566.2011.546058","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"106_CR55","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/01.CHI.0000046863.56865.FE","volume":"42","author":"JT McCracken","year":"2003","unstructured":"McCracken JT, Biederman J, Greenhill LL, Swanson JM, McGough JJ, Spencer TJ, Posner K, Wigal S, Pataki C, Zhang Y, Tulloch S (2003) Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD. J Am Acad Child Adolesc Psychiatry 42(6):673\u2013683. doi: 10.1097\/01.CHI.0000046863.56865.FE","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"106_CR56","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/01.CHI.0000046850.56865.CB","volume":"42","author":"JJ McGough","year":"2003","unstructured":"McGough JJ, Biederman J, Greenhill LL, McCracken JT, Spencer TJ, Posner K, Wigal S, Gornbein J, Tulloch S, Swanson JM (2003) Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall. J Am Acad Child Adolesc Psychiatry 42(6):684\u2013691. doi: 10.1097\/01.CHI.0000046850.56865.CB","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"10","key":"106_CR57","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.biopsych.2007.11.008","volume":"63","author":"R Medori","year":"2008","unstructured":"Medori R, Ramos-Quiroga JA, Casas M, Kooij JJ, Niemela A, Trott GE, Lee E, Buitelaar JK (2008) A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit\/hyperactivity disorder. Biol Psychiatry 63(10):981\u2013989. doi: 10.1016\/j.biopsych.2007.11.008","journal-title":"Biol Psychiatry"},{"issue":"5","key":"106_CR58","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s11920-008-0068-4","volume":"10","author":"DW Murray","year":"2008","unstructured":"Murray DW, Arnold LE, Swanson J, Wells K, Burns K, Jensen P, Hechtman L, Paykina N, Legato L, Strauss T (2008) A clinical review of outcomes of the multimodal treatment study of children with attention-deficit\/hyperactivity disorder (MTA). Curr Psychiatry Rep 10(5):424\u2013431","journal-title":"Curr Psychiatry Rep"},{"issue":"4","key":"106_CR59","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0009922810394832","volume":"50","author":"DW Murray","year":"2011","unstructured":"Murray DW, Childress A, Giblin J, Williamson D, Armstrong R, Starr HL (2011) Effects of OROS methylphenidate on academic, behavioral, and cognitive tasks in children 9 to 12\u00a0years of age with attention-deficit\/hyperactivity disorder. Clin Pediatr (Phila) 50(4):308\u2013320. doi: 10.1177\/0009922810394832","journal-title":"Clin Pediatr (Phila)"},{"key":"106_CR60","unstructured":"National Institute for Health and Clinical Excellence (2009) Diagnosis and management of ADHD in children, young people and adults. National Clinical Practice Guideline Number 72. London, UK. http:\/\/www.nice.org.uk\/nicemedia\/pdf\/ADHDFullGuideline.pdf . Accessed 2 July 2012"},{"key":"106_CR61","unstructured":"Novartis Pharmaceuticals Canada Inc. Ritalin\u00ae SR Product Monograph. Revised September 14, 2011. Novartis Pharmaceuticals Canada Inc., Dorval, Quebec"},{"issue":"5","key":"106_CR62","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/CHI.0b013e31819c23ed","volume":"48","author":"E Pappadopulos","year":"2009","unstructured":"Pappadopulos E, Jensen PS, Chait AR, Arnold LE, Swanson JM, Greenhill LL, Hechtman L, Chuang S, Wells KC, Pelham W, Cooper T, Elliott G, Newcorn JH (2009) Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry 48(5):501\u2013510. doi: 10.1097\/CHI.0b013e31819c23ed","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"12","key":"106_CR63","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1177\/0091270007308615","volume":"47","author":"DA Parasrampuria","year":"2007","unstructured":"Parasrampuria DA, Schoedel KA, Schuller R, Gu J, Ciccone P, Silber SA, Sellers EM (2007) Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans. J Clin Pharmacol 47(12):1476\u20131488. doi: 10.1177\/0091270007308615","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"106_CR64","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1542\/peds.80.4.491","volume":"80","author":"WE Pelham Jr","year":"1987","unstructured":"Pelham WE Jr, Sturges J, Hoza J, Schmidt C, Bijlsma JJ, Milich R, Moorer S (1987) Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder. Pediatrics 80(4):491\u2013501","journal-title":"Pediatrics"},{"issue":"2","key":"106_CR65","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1542\/peds.86.2.226","volume":"86","author":"WE Pelham Jr","year":"1990","unstructured":"Pelham WE Jr, Greenslade KE, Vodde-Hamilton M, Murphy DA, Greenstein JJ, Gnagy EM, Guthrie KJ, Hoover MD, Dahl RE (1990) Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline. Pediatrics 86(2):226\u2013237","journal-title":"Pediatrics"},{"issue":"6","key":"106_CR66","doi-asserted-by":"crossref","first-page":"E105","DOI":"10.1542\/peds.107.6.e105","volume":"107","author":"WE Pelham","year":"2001","unstructured":"Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM, Chronis AM, Forehand GL, Nguyen CA, Hoffman MT, Lock TM, Fielbelkorn K, Coles EK, Panahon CJ, Steiner RL, Meichenbaum DL, Onyango AN, Morse GD (2001) Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics 107(6):E105. doi: 10.1542\/peds.107.6.e105","journal-title":"Pediatrics"},{"key":"106_CR67","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/NDT.S9749","volume":"6","author":"M Pennick","year":"2010","unstructured":"Pennick M (2010) Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine. Neuropsychiatr Dis Treat 6:317\u2013327","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"7","key":"106_CR68","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/chi.0b013e318054e724","volume":"46","author":"S Pliszka","year":"2007","unstructured":"Pliszka S (2007) Practice parameter for the assessment and treatment of children and adolescents with attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46(7):894\u2013921. doi: 10.1097\/chi.0b013e318054e724","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"106_CR69","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1176\/appi.ajp.164.6.942","volume":"164","author":"G Polanczyk","year":"2007","unstructured":"Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007) The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164(6):942\u2013948. doi: 10.1176\/appi.ajp.164.6.942","journal-title":"Am J Psychiatry"},{"issue":"6","key":"106_CR70","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1177\/0091270007299759","volume":"47","author":"D Quinn","year":"2007","unstructured":"Quinn D, Bode T, Reiz JL, Donnelly GA, Darke AC (2007) Single-dose pharmacokinetics of multilayer-release methylphenidate and immediate-release methylphenidate in children with attention-deficit\/hyperactivity disorder. J Clin Pharmacol 47(6):760\u2013766. doi: 10.1177\/0091270007299759","journal-title":"J Clin Pharmacol"},{"issue":"7","key":"106_CR71","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2165\/00023210-200822070-00005","volume":"22","author":"JA Ramos-Quiroga","year":"2008","unstructured":"Ramos-Quiroga JA, Bosch R, Castells X, Valero S, Nogueira M, Gomez N, Yelmo S, Ferrer M, Martinez Y, Casas M (2008) Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate : a chart review of Spanish adults with attention-deficit hyperactivity disorder. CNS Drugs 22(7):603\u2013611","journal-title":"CNS Drugs"},{"key":"106_CR72","unstructured":"Shire Canada Inc. Adderall XR\u00ae Product Monograph. December 20, 2011. Shire Canada Inc., Saint-Laurent, Quebec"},{"key":"106_CR73","unstructured":"Shire Canada Inc. Vyvanse\u00ae Product Monograph. December 21, 2011. Shire Canada Inc., Saint-Laurent, Quebec"},{"issue":"4","key":"106_CR74","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/cap.1992.2.279","volume":"2","author":"DJ Safer","year":"1992","unstructured":"Safer DJ (1992) Relative cardiovascular safety of psychostimulants used to treat attention-deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 2(4):279\u2013290. doi: 10.1089\/cap.1992.2.279","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"7","key":"106_CR75","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1592\/phco.2005.25.7.909","volume":"25","author":"RJ Sanchez","year":"2005","unstructured":"Sanchez RJ, Crismon ML, Barner JC, Bettinger T, Wilson JP (2005) Assessment of adherence measures with different stimulants among children and adolescents. Pharmacotherapy 25(7):909\u2013917","journal-title":"Pharmacotherapy"},{"issue":"5","key":"106_CR76","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/00004583-200205000-00010","volume":"41","author":"MG Sawyer","year":"2002","unstructured":"Sawyer MG, Whaites L, Rey JM, Hazell PL, Graetz BW, Baghurst P (2002) Health-related quality of life of children and adolescents with mental disorders. J Am Acad Child Adolesc Psychiatry 41(5):530\u2013537. doi: 10.1097\/00004583-200205000-00010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"106_CR77","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/cap.2007.0039","volume":"18","author":"R Schachar","year":"2008","unstructured":"Schachar R, Ickowicz A, Crosbie J, Donnelly GA, Reiz JL, Miceli PC, Harsanyi Z, Darke AC (2008) Cognitive and behavioral effects of multilayer-release methylphenidate in the treatment of children with attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol 18(1):11\u201324. doi: 10.1089\/cap.2007.0039","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"106_CR78","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1089\/cap.2005.15.637","volume":"15","author":"R Silva","year":"2005","unstructured":"Silva R, Muniz R, Pestreich LK, Brams M, Childress A, Lopez FA (2005) Efficacy of two long-acting methylphenidate formulations in children with attention- deficit\/hyperactivity disorder in a laboratory classroom setting. J Child Adolesc Psychopharmacol 15(4):637\u2013654. doi: 10.1089\/cap.2005.15.637","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"3","key":"106_CR79","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1176\/appi.ajp.163.3.387","volume":"163","author":"TJ Spencer","year":"2006","unstructured":"Spencer TJ, Biederman J, Ciccone PE, Madras BK, Dougherty DD, Bonab AA, Livni E, Parasrampuria DA, Fischman AJ (2006a) PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate. Am J Psychiatry 163(3):387\u2013395. doi: 10.1176\/appi.ajp.163.3.387","journal-title":"Am J Psychiatry"},{"issue":"2","key":"106_CR80","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.clinthera.2006.02.011","volume":"28","author":"TJ Spencer","year":"2006","unstructured":"Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R (2006b) Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit\/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther 28(2):266\u2013279. doi: 10.1016\/j.clinthera.2006.02.011","journal-title":"Clin Ther"},{"issue":"4","key":"106_CR81","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/1087054710367880","volume":"15","author":"TJ Spencer","year":"2011","unstructured":"Spencer TJ, Mick E, Surman CB, Hammerness P, Doyle R, Aleardi M, Kotarski M, Williams CG, Biederman J (2011) A randomized, single-blind, substitution study of OROS methylphenidate (Concerta) in ADHD adults receiving immediate release methylphenidate. J Atten Disord 15(4):286\u2013294. doi: 10.1177\/1087054710367880","journal-title":"J Atten Disord"},{"issue":"2","key":"106_CR82","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00023210-200317020-00004","volume":"17","author":"J Swanson","year":"2003","unstructured":"Swanson J (2003) Compliance with stimulants for attention-deficit\/hyperactivity disorder: issues and approaches for improvement. CNS Drugs 17(2):117\u2013131","journal-title":"CNS Drugs"},{"issue":"1\u20132","key":"106_CR83","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1469-7610.2008.02062.x","volume":"50","author":"JM Swanson","year":"2009","unstructured":"Swanson JM, Volkow ND (2009) Psychopharmacology: concepts and opinions about the use of stimulant medications. J Child Psychol Psychiatry 50(1\u20132):180\u2013193. doi: 10.1111\/j.1469-7610.2008.02062.x","journal-title":"J Child Psychol Psychiatry"},{"key":"106_CR084","doi-asserted-by":"crossref","unstructured":"Swanson J, Gupta S, Lam A, Shoulson I, Lerner M, Modi N, Lindemulder E, Wigal S (2003) Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit\/hyperactivity disorder: proof-of-concept and proof-of-product studies. Arch Gen Psychiatry 60(2):204\u2013211","DOI":"10.1001\/archpsyc.60.2.204"},{"issue":"3 Pt 1","key":"106_CR84","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1542\/peds.113.3.e206","volume":"113","author":"JM Swanson","year":"2004","unstructured":"Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J, Kollins S, Nguyen AS, DeCory HH, Hirshe Dirksen SJ, Hatch SJ (2004) A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit\/hyperactivity disorder in the laboratory school (the COMACS Study). Pediatrics 113(3 Pt 1):e206\u2013e216","journal-title":"Pediatrics"},{"issue":"8","key":"106_CR85","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/chi.0b013e3180686d7e","volume":"46","author":"JM Swanson","year":"2007","unstructured":"Swanson JM, Elliott GR, Greenhill LL, Wigal T, Arnold LE, Vitiello B, Hechtman L, Epstein JN, Pelham WE, Abikoff HB, Newcorn JH, Molina BS, Hinshaw SP, Wells KC, Hoza B, Jensen PS, Gibbons RD, Hur K, Stehli A, Davies M, March JS, Conners CK, Caron M, Volkow ND (2007) Effects of stimulant medication on growth rates across 3\u00a0years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry 46(8):1015\u20131027. doi: 10.1097\/chi.0b013e3180686d7e","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"11","key":"106_CR86","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1592\/phco.22.16.1405.33687","volume":"22","author":"SJ Tulloch","year":"2002","unstructured":"Tulloch SJ, Zhang Y, McLean A, Wolf KN (2002) SLI381 (Adderall XR), a two-component, extended-release formulation of mixed amphetamine salts: bioavailability of three test formulations and comparison of fasted, fed, and sprinkled administration. Pharmacotherapy 22(11):1405\u20131415","journal-title":"Pharmacotherapy"},{"issue":"4","key":"106_CR87","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12402-010-0044-9","volume":"2","author":"E Ban van den","year":"2010","unstructured":"van den Ban E, Souverein PC, Swaab H, van Engeland H, Egberts TC, Heerdink ER (2010) Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45\u00a0years in the Netherlands. Atten Defic Hyperact Disord 2(4):213\u2013220. doi: 10.1007\/s12402-010-0044-9","journal-title":"Atten Defic Hyperact Disord"},{"issue":"18","key":"106_CR88","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/CIRCULATIONAHA.107.189473","volume":"117","author":"VL Vetter","year":"2008","unstructured":"Vetter VL, Elia J, Erickson C, Berger S, Blum N, Uzark K, Webb CL (2008) Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit\/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing. Circulation 117(18):2407\u20132423. doi: 10.1161\/circulationaha.107.189473","journal-title":"Circulation"},{"issue":"11","key":"106_CR89","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1176\/appi.ajp.160.11.1909","volume":"160","author":"ND Volkow","year":"2003","unstructured":"Volkow ND, Swanson JM (2003) Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry 160(11):1909\u20131918","journal-title":"Am J Psychiatry"},{"issue":"8","key":"106_CR90","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1017\/S1092852900013687","volume":"11","author":"RH Weisler","year":"2006","unstructured":"Weisler RH, Biederman J, Spencer TJ, Wilens TE, Faraone SV, Chrisman AK, Read SC, Tulloch SJ (2006) Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr 11(8):625\u2013639","journal-title":"CNS Spectr"},{"issue":"5","key":"106_CR91","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1089\/cap.2006.0101","volume":"17","author":"M Weiss","year":"2007","unstructured":"Weiss M, Hechtman L, Turgay A, Jain U, Quinn D, Ahmed TS, Yates T, Reiz JL, Donnelly GA, Harsanyi Z, Darke AC (2007) Once-daily multilayer-release methylphenidate in a double-blind, crossover comparison to immediate-release methylphenidate in children with attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol 17(5):675\u2013688. doi: 10.1089\/cap.2006.0101","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"106_CR92","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1753-2000-3-17","volume":"3","author":"SB Wigal","year":"2009","unstructured":"Wigal SB, Kollins SH, Childress AC, Squires L (2009) A 13-h laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit\/hyperactivity disorder. Child Adolesc Psychiatry Ment Health 3(1):17. doi: 10.1186\/1753-2000-3-17","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"106_CR93","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1744-9081-6-34","volume":"6","author":"T Wigal","year":"2010","unstructured":"Wigal T, Brams M, Gasior M, Gao J, Squires L, Giblin J (2010) Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder: novel findings using a simulated adult workplace environment design. Behav Brain Funct 6:34. doi: 10.1186\/1744-9081-6-34","journal-title":"Behav Brain Funct"},{"issue":"2","key":"106_CR94","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/cap.2010.0047","volume":"21","author":"SB Wigal","year":"2011","unstructured":"Wigal SB, Wigal T, Schuck S, Brams M, Williamson D, Armstrong RB, Starr HL (2011) Academic, behavioral, and cognitive effects of OROS(R) methylphenidate on older children with attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol 21(2):121\u2013131. doi: 10.1089\/cap.2010.0047","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"106_CR95","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4088\/JCP.v66n0215","volume":"66","author":"TE Wilens","year":"2005","unstructured":"Wilens TE, Hammerness PG, Biederman J, Kwon A, Spencer TJ, Clark S, Scott M, Podolski A, Ditterline JW, Morris MC, Moore H (2005) Blood pressure changes associated with medication treatment of adults with attention-deficit\/hyperactivity disorder. J Clin Psychiatry 66(2):253\u2013259","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"106_CR96","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpedi.160.1.82","volume":"160","author":"TE Wilens","year":"2006","unstructured":"Wilens TE, McBurnett K, Bukstein O, McGough J, Greenhill L, Lerner M, Stein MA, Conners CK, Duby J, Newcorn J, Bailey CE, Kratochvil CJ, Coury D, Casat C, Denisco MJ, Halstead P, Bloom L, Zimmerman BA, Gu J, Cooper KM, Lynch JM (2006a) Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit\/hyperactivity disorder. Arch Pediatr Adolesc Med 160(1):82\u201390. doi: 10.1001\/archpedi.160.1.82","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"3","key":"106_CR97","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1542\/peds.2006-0942","volume":"118","author":"TE Wilens","year":"2006","unstructured":"Wilens TE, Prince JB, Spencer TJ, Biederman J (2006b) Stimulants and sudden death: what is a physician to do? Pediatrics 118(3):1215\u20131219. doi: 10.1542\/peds.2006-0942","journal-title":"Pediatrics"},{"issue":"1","key":"106_CR98","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/chi.0b013e31815a56f1","volume":"47","author":"TE Wilens","year":"2008","unstructured":"Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, Utzinger L, Fusillo S (2008) Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry 47(1):21\u201331. doi: 10.1097\/chi.0b013e31815a56f1","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"106_CR99","doi-asserted-by":"crossref","first-page":"e1494","DOI":"10.1542\/peds.2007-0675","volume":"120","author":"AG Winterstein","year":"2007","unstructured":"Winterstein AG, Gerhard T, Shuster J, Johnson M, Zito JM, Saidi A (2007) Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit\/hyperactivity disorder. Pediatrics 120(6):e1494\u2013e1501. doi: 10.1542\/peds.2007-0675","journal-title":"Pediatrics"},{"issue":"1","key":"106_CR100","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1542\/peds.2008-3138","volume":"124","author":"AG Winterstein","year":"2009","unstructured":"Winterstein AG, Gerhard T, Shuster J, Saidi A (2009) Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD. Pediatrics 124(1):e75\u2013e80. doi: 10.1542\/peds.2008-3138","journal-title":"Pediatrics"},{"issue":"4","key":"106_CR101","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1542\/peds.108.4.883","volume":"108","author":"ML Wolraich","year":"2001","unstructured":"Wolraich ML, Greenhill LL, Pelham W, Swanson J, Wilens T, Palumbo D, Atkins M, McBurnett K, Bukstein O, August G (2001) Randomized, controlled trial of OROS methylphenidate once a day in children with attention-deficit\/hyperactivity disorder. Pediatrics 108(4):883\u2013892","journal-title":"Pediatrics"},{"key":"106_CR102","volume-title":"Adherence to long-term therapies: evidence for action","author":"World Health Organization","year":"2003","unstructured":"World Health Organization (2003) Adherence to long-term therapies: evidence for action. World Health Organization, Geneva"}],"container-title":["ADHD Attention Deficit and Hyperactivity Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12402-013-0106-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12402-013-0106-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12402-013-0106-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T04:45:03Z","timestamp":1644727503000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12402-013-0106-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,6]]},"references-count":103,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["106"],"URL":"https:\/\/doi.org\/10.1007\/s12402-013-0106-x","relation":{},"ISSN":["1866-6116","1866-6647"],"issn-type":[{"value":"1866-6116","type":"print"},{"value":"1866-6647","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,6]]}}}